Aortic and hepatic peak enhancement at CT: Effect of contrast medium injection rate - Pharmacokinetic analysis and experimental porcine model

Radiology

Volumn 206, Issue 2, 1998, Pages 455-464

  Bae, Kyongtae T ^a   Heiken, Jay P ^a   Brink, James A ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta, CT; Computed tomography (CT), contrast media; Computed tomography (CT), technology; Liver, CT

Indexed keywords

CONTRAST MEDIUM; MEGLUMINE IOTALAMATE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; COMPARTMENT MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; LIVER; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SIMULATION; SWINE; THEORY;

EID: 0031952417     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.2.9457200     Document Type: Article

References (20)

1. Berland LL. Slip-ring and conventional dynamic hepatic CT: contrast material and timing considerations. Radiology 1995; 195:1-8.
2. Garcia PA, Bonaldi VM, Bret PM, Liang L, Reinhold C, Atri M. Effect of rate of contrast medium injection on hepatic enhancement at CT. Radiology 1996; 199: 185-189.
3. Irie T, Suzuki S, Yamauchi T, Kusano S. Prediction of the time to peak hepatic enhancement to optimize contrast-enhanced spiral CT. Acta Radiol 1995; 36: 154-158.
4. Kuhns LR. Optimal timing of abdominal CT in children: relationship to injection rate. Radiology 1993; 189:49-51.
5. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. II. Alterations in contrast material volume and rate of injection within the same patients. Radiology 1994; 193:518-522.
6. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Invest Radiol 1980; 15:158-161.
7. Heiken JP, Brink JA, McClennan BL, Sagel SS, Forman HP, DiCroce J. Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology 1993; 187:327-331.
8. Olsson B, Aulie A, Sveen K, Andrew E. Human pharmacokinetics of iohexol: a new nonionic contrast medium. Invest Radiol 1983; 18:177-182.
9. Guyton AC. Textbook of medical physiology. 7th ed. Philadelphia, Pa: Saunders, 1986.
10. Bae KT, Heiken JP, Brink JA. Computer simulation of contrast enhancement at CT: prediction of aortic and hepatic enhancement during abdominal CT (abstr). Radiology 1995; 197(P):138.
11. Dawson P, Blomley MJ. Contrast agent pharmacokinetics revisited. I. Reformulation. Acad Radiol 1996; 3(suppl):S261-S263.
12. Krause W. Application of pharmacokinetics to computed tomography: injection rates and schemes - mono-, bi-, or multiphasic? Invest Radiol 1996; 31:91-100.
13. Yankelevitz DF, Henschke CI. Simple method for maximizing pulmonary arterial opacification during CT angiography (abstr). Radiology 1996; 201(P):304.
14. Hannon JP, Bossone CA, Wade CE. Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 1990; 40:293-298.
15. Claussen CD, Banzer D, Pfretzschner C, Kalender WA, Schorner W. Bolus geometry and dynamics after intravenous contrast medium injection. Radiology 1984; 153:365-368.
16. Walkey M. Don't upset my equilibrium again (letter). AJR 1995; 164:1023-1024.
17. Dawson P, Blomley M. Definition of "equilibrium point" (letter). Radiology 1996; 200:288-289.
18. Bae KT, Brink JA, Heiken JP. Definition of "equilibrium point" (reply). Radiology 1996; 200:288-289.
19. Foley WD. Dynamic hepatic CT. Radiology 1989; 170:617-622.
20. Small WC, Nelson RC, Bernardino ME, Brummer LT. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement. AJR 1994; 163:87-92.